Previous Close | 23.77 |
Open | 24.19 |
Bid | 23.91 x 0 |
Ask | 23.95 x 0 |
Day's Range | 23.72 - 26.80 |
52 Week Range | 2.65 - 40.93 |
Volume | 8,250,115 |
Avg. Volume | 6,832,628 |
Market Cap | 7.577B |
Beta (5Y Monthly) | 2.52 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.79 |
Earnings Date | Apr 12, 2021 - Apr 16, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 16.04 |
Following a more than one-year downtrend, there's no longer any doubt about it: Marijuana stocks are back in a big way. The excitement surrounding pot stocks was readily evident when analyzing their monthly returns in February. Whereas the benchmark S&P 500 ended last month higher by 2.6%, 10 marijuana stocks crossed the finish line with a gain of at least 20%.
Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY) expect to close their planned merger in the second quarter of this year. Both cannabis stocks have been big winners so far in 2021 in anticipation of the combination of the two companies. Aphria's shares are up over 170%, while Tilray stock has more than tripled year to date.
Aphria Inc. (APHA) closed the most recent trading day at $18.95, moving +1.01% from the previous trading session.